CVS Health (CVS) Scheduled to Post Quarterly Earnings on Wednesday

CVS Health (NYSE:CVS) is set to release its earnings data before the market opens on Wednesday, November 6th. Analysts expect CVS Health to post earnings of $1.08 per share for the quarter. CVS Health has set its FY24 guidance at $6.40-6.65 EPS and its FY 2024 guidance at 6.400-6.650 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same period in the prior year, the company posted $2.21 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. On average, analysts expect CVS Health to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CVS Health Stock Performance

Shares of CVS stock opened at $54.65 on Tuesday. CVS Health has a 12-month low of $52.77 and a 12-month high of $83.25. The firm has a market capitalization of $68.75 billion, a price-to-earnings ratio of 9.72, a price-to-earnings-growth ratio of 0.83 and a beta of 0.55. The business has a 50 day simple moving average of $59.58 and a 200 day simple moving average of $59.39. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.87%. The ex-dividend date was Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 47.33%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CVS shares. Barclays decreased their price objective on CVS Health from $82.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft cut their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Royal Bank of Canada restated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Truist Financial upped their target price on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $73.11.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.